Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v2-FR
Language English French
Date Updated 2021-11-26 2021-08-04
Drug Identification Number 02466074 02466074
Brand name TARO-ACITRETIN TARO-ACITRETIN
Common or Proper name ACETRETIN ACETRETIN
Company Name TARO PHARMACEUTICALS INC TARO PHARMACEUTICALS INC
Ingredients ACITRETIN ACITRETIN
Strength(s) 10MG 10MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 30
ATC code D05BB D05BB
ATC description ANTIPSORIATICS FOR SYSTEMIC USE ANTIPSORIATICS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-07-20 2021-07-20
Estimated end date 2021-10-29 2021-09-24
Actual end date 2021-10-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments